Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.
Reward Minerals (ASX:RWD)
Reward Minerals subsidiary Holocene applied for a new exploration license prospective for gypsum. The application area includes historic mining tenement areas where auger drilling, costeaning and test pitting by multiple explorers defined "substantial" gypsum deposits.
Western Mines Group (ASX:WMG)
Western Mines Group completed the first mineral resource estimate for the shallow disseminated nickel sulfide mineralization at the Mulga Tank project in Western Australia.
Miramar Resources (ASX:M2R)
Miramar Resources secured a drill rig for gold exploration expected to start next week at the Gidji joint venture project in Western Australia.
Gold Mountain (ASX:GMN)
Gold Mountain launched a one-for-three pro rata accelerated renounceable entitlement offer, offering retail rights trading of new shares at a price of AU$0.002 apiece. The offer aims to raise up to AU$3.1 million, with one attaching option for every new share issued.
Argent BioPharma (ASX:RGT)
Argent BioPharma's cannabinoid-based therapy for refractory epilepsy, CannEpil, received approval for prescription in Germany under a special access scheme.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.